US 7354576
Methods of treating diseases caused by deficiencies of recombinant α-L-iduronidase
granted A61KA61K38/47A61K48/00
Quick answer
US patent 7354576 (Methods of treating diseases caused by deficiencies of recombinant α-L-iduronidase) held by BIOMARIN PHARMACEUTICAL INC. expires Mon Apr 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- BIOMARIN PHARMACEUTICAL INC.
- Grant date
- Tue Apr 08 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K38/47, A61K48/00, A61P, A61P19/00